tm logo
BIOSYNTH
REGISTERED

on 19 Oct 2018

Last Applicant/ Owned by

BIOSYNTH AG (A SWITZERLAND CORPORATION)

P.O. Box 125Staad 9422

CH

Serial Number

1788341 filed on 23rd Jun 2016

Registration Number

TMA1007169 registered on 19th Oct 2018

Registration expiry Date

19th Oct 2033

Correspondent Address

99 BANK STREETSUITE 1420OTTAWA

ONTARIO

CA

K1P1H4

BIOSYNTH

Trademark usage description

medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; chemical r Read More

Classification Information


Class [005]
Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; chemical reagents for medical or veterinary purposes, namely, diagnostic reagents for medical and veterinary diagnostic use, diagnostic reagents for medical and veterinary laboratory use, diagnostic reagents for medical and veterinary research use; chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; cultures of microorganisms for medical or veterinary use; microorganism preparations, namely, cultures of microorganisms for medical or veterinary use; chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; chemical preparations for medical purposes, namely, for immunology research; organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); medical enzyme namely, enzymes for removing adherent cells from a culture surface in human or animal cell cultures, enzymes for the digestion of peptides in biochemical and biomedical analysis in the manufacturing of diagnostic kits and reagents, enzymes for the break down cell walls of microorganisms used to release nucleic acids from bacteria or yeast in bio-medical research, enzymes used to digest complex sample matrices to release DNA for forensic analysis, enzymes used to prepare spheroplasts for research, enzymes for the break down specific carbohydrates, enzymes used in biomedical research, enzymes used in medical diagnostics, enzymes used in bio-catalysis for the production of intermediates and pharmaceutical compounds, enzymes to remove specific nucleic acids in genomic diagnosis and genomic research, enzymes that form bioluminescence signals from luciferin substrates used for medical or veterinary use and in general hygiene monitoring.


Classification kind code

10

Mark Details


Serial Number

1788341

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 20th Jul 2018
Allowed
Submitted for opposition 42
on 04th Apr 2018
Advertised
Submitted for opposition 26
on 15th Mar 2018
Approved
Submitted for opposition 27
on 23rd Jan 2018
Approval Notice Sent
Submitted for opposition 15
on 05th Oct 2017
Correspondence Created
Submitted for opposition 22
on 24th Jan 2017
Search Recorded
Submitted for opposition 20
on 24th Jan 2017
Examiner's First Report
Submitted for opposition 31
on 28th Jun 2016
Formalized
Submitted for opposition 30
on 23rd Jun 2016
Filed
Submitted for opposition 1
on 23rd Jun 2016
Created